Moderna, Inc.MRNANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank9
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P9
Near historical low
vs 3Y Ago
-6.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -229.62% |
| Q3 2025 | 71.33% |
| Q2 2025 | 13.62% |
| Q1 2025 | 15.73% |
| Q4 2024 | -1680.00% |
| Q3 2024 | 94.86% |
| Q2 2024 | -7.66% |
| Q1 2024 | -21200.00% |
| Q4 2023 | 100.30% |
| Q3 2023 | -7.77% |
| Q2 2023 | -410.11% |
| Q1 2023 | -123.16% |
| Q4 2022 | 35.51% |
| Q3 2022 | -52.35% |
| Q2 2022 | -42.11% |
| Q1 2022 | -21.87% |
| Q4 2021 | 52.05% |
| Q3 2021 | 16.20% |
| Q2 2021 | 141.86% |
| Q1 2021 | 560.30% |
| Q4 2020 | -16.98% |
| Q3 2020 | -92.52% |
| Q2 2020 | 6.67% |
| Q1 2020 | -0.23% |
| Q4 2019 | 0.16% |
| Q3 2019 | 9.01% |
| Q2 2019 | -1.46% |
| Q1 2019 | 7.44% |
| Q4 2018 | -78.32% |
| Q3 2018 | 11.54% |
| Q2 2018 | -25.34% |
| Q1 2018 | -85.05% |
| Q4 2017 | 38.37% |
| Q3 2017 | 14.98% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |